Responsibility reports

We report on a wide range of data in our Responsible Business Performance Report and provide additional ratings and disclosures below.

Latest reports

The Responsible Business Performance Report includes our performance across our six environmental, social and governance priority areas, and includes ESG data for current and previous years. Within the Responsible Business section of our Annual Report, we provide a summary and highlights of our progress in 2024.

Lungs Science Image

Our position on

Learn more about our views and our practices across a range of access, R&D, intellectual property, health security and environment issues here.

Responsibility reports archive

Search our archive of responsible business reports and resources dating back to 2002.

 

External ratings  

 

External benchmarking Current rating
Previous rating
Comments
S&P Global's Corporate Sustainability Assessment 78 80 Current score updated September 2024
Access to Medicines Index 3.72 4.06 Second in the Index, updated bi-annually, current results from November 2024
Antimicrobial Resistance Benchmark 84% 86% Led the benchmark since its inception in 2018; Current ranking updated November 2021
CDP Climate change A A- Updated annually, current score updated February 2025 (for supplier engagement, July 2025) 
CDP Water security A A- Updated annually, current score updated February 2025 (for supplier engagement, July 2025) 
CDP Forests (palm oil) B B Updated annually, current score updated February 2025 (for supplier engagement, July 2025) 
CDP Forests (timber) B B Updated annually, current score updated February 2025 (for supplier engagement, July 2025) 
CDP Supplier engagement rating Leader Leader Updated annually, current score updated February 2025 (for supplier engagement, July 2025) 
Sustainalytics 14.8 15.0 1st percentile in pharma subindustry group; lower score represents lower risk. Current score as at July 2025
MSCI AA AA Last rating action date: September 2023
Moody's ESG solutions 62 61 Current score updated August 2023
ISS Corporate Rating B+ B+ Current score updated October 2024
FTSE4Good Member  Member  Member since 2004, latest review in June 2024
ShareAction’s Workforce Disclosure Initiative  79% 77% Current score updated January 2024

Updated July 2025​

Disclosure

_